NCT05493657View on ClinicalTrials.gov

Aspirin vs Clopidogrel After TAVR

NARecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

February 2, 2023

Primary Completion Date

July 21, 2026

Study Completion Date

July 21, 2027

Conditions
Severe Aortic Stenosis
Interventions
DRUG

Aspirin single antiplatelet therapy

Patients receive the aspirin (100 mg/day) single antiplatelet therapy after 4 weeks of dual antiplatelet therapy of aspirin (100 mg/day) and clopidogrel (75 mg/day) after TAVR.

DRUG

Clopidogrel single antiplatelet therapy

Patients receive the clopidogrel (75 mg/day) single antiplatelet therapy after 4 weeks of dual antiplatelet therapy of aspirin (100 mg/day) and clopidogrel (75 mg/day) after TAVR.

Trial Locations (1)

Unknown

RECRUITING

Yonsei University Health System, Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER